"renal accessory arteries" trang 11 - tải miễn phí từ tailieuXANH
Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis

Pazopanib has equivalent anti-tumor effectiveness and lower Total costs than Sunitinib for treating metastatic or advanced renal cell carcinoma: A metaanalysis
12    52    0
Collagen organization of renal cell carcinoma differs between low and high grade tumors

Collagen organization of renal cell carcinoma differs between low and high grade tumors
8    63    0
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database

Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
15    44    0
Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma

Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
12    61    0
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis
13    68    0
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
9    59    0
Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas

Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
13    57    0
PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma

PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma
9    71    0
Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer

Nrf2 gene mutation and single nucleotide polymorphism rs6721961 of the Nrf2 promoter region in renal cell cancer
9    64    0
UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
11    57    0
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
10    58    0
Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma
10    50    0
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study

Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: A multi-center, retrospective cohort study
11    68    0
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma

Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
8    85    0
Summary thesis of Medical Doctor: Study on malnutrition status and serum leptin levels in end-stage renal disease patient is on maintenance hemodialysis and outpatients continuous peritoneal dialysis

Summary thesis of Medical Doctor: Study on malnutrition status and serum leptin levels in end-stage renal disease patient is on maintenance hemodialysis and outpatients continuous peritoneal dialysis
27    96    0
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
12    77    0
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens

Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: A comprehensive observation in radical nephrectomy specimens
7    99    0
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: Data from a national registry
8    82    0
Advanced sporadic renal epithelioid angiomyolipoma: Case report of an extraordinary response to sirolimus linked to TSC2 mutation

Advanced sporadic renal epithelioid angiomyolipoma: Case report of an extraordinary response to sirolimus linked to TSC2 mutation
5    71    0
Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/ G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/ G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
17    76    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.